Pfizer Statistics, Revenue Totals, Facts & News (2022)
Last Updated on: March 31st, 2022
Here are a few of the most interesting Pfizer statistics and facts I was able to dig up including revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.
Pfizer Facts
- Pfizer Website: Official Website
- Year Pfizer was Founded: 1849
- Pfizer Headquarters: New York City
- Pfizer Founder(s): Charles Pfizer and Charles Erhart
- Current Pfizer Chief Executive: Ian Read
- Pfizer Subsidiaries / Brands: Viagara, Lyrica, Zyvox, Relpax, Vfend, Tygacil and Pristiq
What is Pfizer?
Breakthroughs That Change Patients’ Lives: Pfizer is a leading research-based biopharmaceutical company. We apply science and our global resources to deliver innovative therapies that extend and significantly improve lives. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. (source)
Pfizer Revenue Totals
Pfizer annual revenue:
- 2021: $81.3 billion
- 2020: $41.9 billion
- 2019: $51.8 billion
- 2018: $53.6 billion
- 2017: $52.5 billion
- 2016: $52.8 billion
- 2015: $48.9 billion
Pfizer annual net income:
- 2021: $21.979 billion
- 2020: $9.616 billion
- 2019: $16.298 billion
- 2018: $11.885 billion
- 2017: $21.308 billion
- 2016: $7.215 billion
- 2015: $6.960 billion
Additional Pfizer Statistics
Number of countries Pfizer products are sold in:
Last updated 1/1/19
Recent Pfizer News
- Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates, 04/08/2022
- Pfizer to buy rest of Biohaven for $11.6B, 05/16/2022
- Pfizer Completes Acquisition of Arena Pharmaceuticals, 03/19/2022
- Biohaven and Pfizer Receive Positive CHMP Opinion for Migraine Treatment, 02/28/2022
- Pfizer Invites Public to View and Listen to Webcast of February 8 Conference Call with Analysts, 01/02/2022
- Pfizer Announces New Chief Development Officer, 02/02/2022
- Pfizer and Ionis announce discontinuation of vupanorsen clinical development program, 01/31/2022
Related posts:
Please note that some of these numbers are easier to find than others. A few of these Pfizer stats come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%.
Related Categories:
Related Tags: